This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help people with weakened immune systems maintain protection against RSV.
RSV Vaccine Study for People with Weakened Immune Systems
Age Range:
18 to 100
Gender:
Male and Female
Location:
Rochester, New York
About the Study
RSV is a contagious respiratory virus that can lead to hospitalization and other complications, especially in adults with weakened immune systems.
Pfizer’s RSV vaccine (ABRYSVO®) has already helped protect millions of people around the world who are at increased risk of severe illness from RSV. However, people with weakened immune systems may lose vaccine protection faster than others.
If this clinical trial is a good fit for you and you agree to take part, you will be in the study for about 1 year and have up to 5 visits with the study team.
You will receive 1 injection (shot) of Pfizer’s RSV vaccine. There is no placebo (injection with no active ingredients) in this study.
There is no cost to participate, and health insurance is not required. Compensation for time and travel is available and will be explained by the study team.
Qualifications
This study is enrolling adults who:
- Are 18 years of age or older
- Have never received an RSV vaccine OR have received at least 1 dose of Pfizer’s RSV vaccine
- Have a weakened immune system
You may qualify for this study if you meet any of the following criteria for having a weakened immune system:
- Have an autoimmune disease (e.g., rheumatoid or psoriatic arthritis, lupus, scleroderma, etc.) and take medication to regulate your immune system
- Have had certain transplants
- Are receiving or recently completed chemotherapy
The study team will discuss additional requirements with you and help you decide if this study is right for you.
FEATURED STUDIES
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]